Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S Common Stock
(NY:
NVO
)
58.20
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novo Nordisk A/S Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
96
97
Next >
Dow Futures Surge After Fed Signals Possibility Of More Rate Cuts This Year: META, PLTR, PYPL, GOOGL Among Stocks To Watch
Today 7:21 EDT
Via
Stocktwits
Topics
Economy
Stocks
Novo Nordisk Stock Jumps After-Hours On Wegovy Pill Breakthrough As Weight-Loss War With Eli Lilly Heats Up
September 17, 2025
The Danish drugmaker has already filed the once-daily pill with U.S. regulators, aiming for the first FDA-approved oral GLP-1 treatment for obesity.
Via
Stocktwits
Why Novo Nordisk Stock Popped Today
September 17, 2025
Novo Nordisk lost half its value over the past year. Is it cheap enough to buy now?
Via
The Motley Fool
Eli Lilly Says Its Obesity Pill Topped Novo Nordisk’s Oral Drug In Late-Stage Diabetes Trial
September 17, 2025
Via
Stocktwits
Class Action Filed Against Novo Nordisk A/S (NVO) Seeking Recovery for Investors - Contact Levi & Korsinsky
September 17, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
US FDA Alleges Novo Nordisk’s Video On Weight-loss Drugs Featuring Oprah Winfrey Is ‘False Or Misleading’
September 16, 2025
Via
Stocktwits
Novo Nordisk Says New Obesity Treatment Achieved 11.8% Body Weight Reduction In Late-stage Study
September 16, 2025
Via
Stocktwits
Class Action Filed Against Novo Nordisk A/S (NVO) Seeking Recovery for Investors - Contact Levi & Korsinsky
September 17, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
2 High-Yield Dividend Stocks You'll Wish You Had Bought 10 Years From Now
September 17, 2025
These dividend payers cranked up their payouts over the past decade, and they could do it again.
Via
The Motley Fool
Why Novo Nordisk Stock Popped Today
September 16, 2025
The Wegovy maker reported positive results from a clinical trial of a next-generation obesity treatment.
Via
The Motley Fool
Novo Nordisk Navigates a GLP-1 Gold Rush: Soaring Obesity Drug Sales Clash with Revised Outlook Amidst Mounting Competition
September 16, 2025
Copenhagen, Denmark – Pharmaceutical giant Novo Nordisk (NYSE: NVO) has reported a robust second quarter for 2025, with impressive revenue and net income figures largely propelled by the formidable...
Via
MarketMinute
Topics
Earnings
Economy
Intellectual Property
Hims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic, Wegovy
September 16, 2025
FDA warns Hims & Hers that its semaglutide products are misbranded due to misleading claims and asks for corrective steps within 15 days.
Via
Benzinga
Stock Of The Day: Is The Novo Nordisk Death Spiral Finally Over?
September 16, 2025
Novo Nordisk has been in a downtrend for more than a year. But a reversal may be underway, and a rally may follow.
Via
Benzinga
Wegovy's Next Step: Novo Nordisk Eyes Approval for Higher-Dose Treatment
September 16, 2025
Novo Nordisk plans to seek FDA approval for a high-dose Wegovy, matching Eli Lilly's Zepbound with another weight-loss option for patients.
Via
Benzinga
3 Undervalued Healthcare Stocks to Buy Now While They're Cheap
September 16, 2025
In an otherwise hot stock market, healthcare stocks are underperforming.
Via
The Motley Fool
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights - NVO
September 16, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights - NVO
September 16, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Here Is My Top Stock Pick Among the Weight Loss Industry Leaders
September 16, 2025
The weight loss drug market may reach $95 billion within five years.
Via
The Motley Fool
What's Going On With Novo Nordisk Shares Monday?
September 15, 2025
Novo Nordisk shares are trading higher Monday after the company announced European Union approval for oral semaglutide to reduce cardiovascular death, heart attack and stroke.
Via
Benzinga
Novo Nordisk's Rybelsus Now First Oral GLP-1 RA In Europe With Proven Heart Health Impact
September 15, 2025
EMA approved Rybelsus' label update after the SOUL trial showed it cuts heart attack, stroke, and death by 14% in high-risk type 2 diabetes patients.
Via
Benzinga
Novo Nordisk's Weight-Loss Wonders Drive Q2 Growth Amidst Shifting Sands of Competition
September 15, 2025
Novo Nordisk (NYSE: NVO) has once again demonstrated formidable strength in its obesity care segment, with powerhouse drugs Wegovy and Ozempic propelling the company to a robust Q2 2025 performance....
Via
MarketMinute
Topics
Economy
Intellectual Property
Novo Nordisk Faces Headwinds: Competitive Pressures and Compounded Drugs Force Lowered Outlook
September 15, 2025
Copenhagen, Denmark – Novo Nordisk (NASDAQ: NVO), the pharmaceutical powerhouse synonymous with diabetes and obesity care, has significantly pared back its full-year sales and profit projections for...
Via
MarketMinute
Topics
Economy
Intellectual Property
Law Enforcement
Why Novo Nordisk Stock Popped Today
September 15, 2025
A price cut could help get Novo Nordisk stock back in the race against Eli Lilly.
Via
The Motley Fool
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NVO
September 15, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NVO
September 15, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
NOVO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S and Encourages Investors to Contact the Firm
September 15, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S (NYSE: NVO)
September 15, 2025
From
Bernstein Liebhard LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO
September 14, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Hims & Hers Faces FDA Heat As Commissioner Martin Makary Calls Out Super Bowl Ad For Hiding Drug Risks
September 13, 2025
FDA Commissioner Martin Makary said Hims & Hers broke federal law with its Super Bowl ad promoting weight-loss drugs without disclosing side effects, and called it "the most overt breach" of FDA...
Via
Benzinga
NVO LAWSUIT ALERT: Levi & Korsinsky Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline
September 12, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
< Previous
1
2
3
4
5
6
7
8
9
...
96
97
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.